Medly

Medly, a once-prominent pharmacy startup in the healthcare industry, is permanently shutting down in February 2024 after declaring bankruptcy in December 2023. The company is laying off all remaining employees as it closes its 22 pharmacies, with staff being let go by the end of the month. While the exact number of affected employees isn't specified, the shutdown follows months of financial turmoil, with Medly burning through cash due to overly rapid expansion in a competitive, low-margin sector. Its patient data and drug inventory were sold to Walgreens, which has expressed interest in hiring some former Medly staff, though no severance will be paid due to the Chapter 11 bankruptcy.

Pharmacy startup Medly is cutting nearly half its workforce, laying off around 200 employees as part of a restructuring effort. The company, which operates in the health care and technology industry, had grown rapidly but is now scaling back to streamline operations and focus on profitability. This significant reduction, announced in September 2022, reflects broader challenges in the startup sector amid shifting market conditions.

Medly, a pharmacy and healthcare delivery company, laid off approximately 16% of its workforce in a difficult round of cuts. The layoffs, announced by an executive in a LinkedIn post, affected employees across all departments, including product managers, designers, and software engineers. The decision was described as the hardest day of the executive's career, indicating internal restructuring or economic pressures as the likely context. The company, which operates in the competitive health-tech industry, undertook this reduction to streamline operations, though the exact total number of employees impacted was not specified in the announcement.